| Literature DB >> 30122555 |
H Furkan Alkan1, Katharina E Walter2, Alba Luengo3, Corina T Madreiter-Sokolowski4, Sarah Stryeck4, Allison N Lau3, Wael Al-Zoughbi5, Caroline A Lewis6, Craig J Thomas7, Gerald Hoefler8, Wolfgang F Graier9, Tobias Madl9, Matthew G Vander Heiden10, Juliane G Bogner-Strauss11.
Abstract
Mitochondrial function is important for aspartate biosynthesis in proliferating cells. Here, we show that mitochondrial aspartate export via the aspartate-glutamate carrier 1 (AGC1) supports cell proliferation and cellular redox homeostasis. Insufficient cytosolic aspartate delivery leads to cell death when TCA cycle carbon is reduced following glutamine withdrawal and/or glutaminase inhibition. Moreover, loss of AGC1 reduces allograft tumor growth that is further compromised by treatment with the glutaminase inhibitor CB-839. Together, these findings argue that mitochondrial aspartate export sustains cell survival in low-glutamine environments and AGC1 inhibition can synergize with glutaminase inhibition to limit tumor growth.Entities:
Keywords: AGC1; Aralar; SLC25A12; aspartate-glutamate carrier; cancer metabolism; glutamine metabolism
Mesh:
Substances:
Year: 2018 PMID: 30122555 PMCID: PMC6390946 DOI: 10.1016/j.cmet.2018.07.021
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 31.373